NextCure, Inc. Report issue

For profit Phase 2
Founded: Washington DC United States (2015)

Organization Overview

First Clinical Trial
2018
NCT03665285
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NextCure, Inc.